Ignacio Wistuba Selected Research

Poly(ADP-ribose) Polymerase Inhibitors

4/2017

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ignacio Wistuba Research Topics

Disease

66	Neoplasms (Cancer) 02/2024 - 08/2004
24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2006
20	Lung Neoplasms (Lung Cancer) 10/2023 - 08/2010
12	Adenocarcinoma of Lung 01/2023 - 04/2008
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2021 - 04/2017
5	Adenocarcinoma 01/2015 - 04/2006
4	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2010
4	Carcinoma (Carcinomatosis) 01/2022 - 04/2007
3	Inflammation (Inflammations) 07/2021 - 04/2006
3	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 02/2011
3	Malignant Mesothelioma 06/2014 - 10/2009
2	Mouth Neoplasms (Oral Cancer) 01/2019 - 11/2009
2	Mesothelioma 06/2014 - 04/2009
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 05/2013 - 02/2011
2	Carcinogenesis 04/2008 - 04/2006
1	Sarcoma (Soft Tissue Sarcoma) 02/2024
1	Liposarcoma 02/2024
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Cholangiocarcinoma 01/2022
1	Febrile Neutropenia 11/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2012
9	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2007
7	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2019
6	Tyrosine Kinase InhibitorsIBA 03/2018 - 08/2010
6	ErbB Receptors (EGF Receptor)IBA 11/2017 - 03/2006
5	DNA (Deoxyribonucleic Acid)IBA 05/2019 - 12/2008
4	NivolumabIBA 02/2024 - 01/2019
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 05/2014
3	Hormones (Hormone)IBA 01/2023 - 11/2017
3	EnzymesIBA 05/2022 - 07/2021
3	Pemetrexed (MTA)FDA Link 01/2022 - 02/2011
3	B7-H1 AntigenIBA 01/2022 - 10/2018
3	AntibodiesIBA 01/2022 - 01/2019
3	Circulating Tumor DNAIBA 10/2021 - 01/2018
3	ParaffinIBA 01/2021 - 01/2015
3	theasinensin AIBA 01/2021 - 09/2015
3	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2015
3	Formaldehyde (Formol)FDA Link 01/2021 - 01/2015
3	Messenger RNA (mRNA)IBA 10/2019 - 09/2014
3	Phosphotransferases (Kinase)IBA 11/2017 - 05/2012
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2014 - 11/2012
3	Sorafenib (BAY 43-9006)FDA Link 12/2013 - 11/2012
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2009 - 07/2007
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2022 - 11/2021
2	Peptides (Polypeptides)IBA 01/2022 - 01/2019
2	liquid crystal polymerIBA 01/2022 - 01/2021
2	Phenobarbital (Luminal)FDA Link 07/2021 - 01/2020
2	Histone Deacetylases (Histone Deacetylase)IBA 10/2019 - 09/2015
2	pyrimidineIBA 05/2019 - 01/2017
2	Thyroid Nuclear Factor 1IBA 01/2019 - 05/2013
2	LigandsIBA 10/2017 - 04/2006
2	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 01/2017
2	MucinsIBA 05/2013 - 02/2011
2	vandetanib (ZD6474)IBA 05/2013 - 11/2012
2	Bexarotene (LGD1069)FDA Link 05/2013 - 11/2012
2	Colloids (Colloid)IBA 05/2013 - 02/2011
2	Dasatinib (BMS 354825)FDA Link 05/2012 - 10/2010
1	IpilimumabIBA 02/2024
1	Hematoxylin (Haematoxylon)IBA 10/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2023
1	Carbamyl Phosphate (Carbamoyl Phosphate)IBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023
1	GlucocorticoidsIBA 01/2023
1	Testosterone (Sustanon)FDA Link 01/2023
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2023
1	Tryptophan (L-Tryptophan)FDA Link 05/2022
1	kynureninaseIBA 05/2022
1	KynurenineIBA 05/2022
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 01/2022
1	Keratins (Keratin)IBA 01/2022
1	urelumabIBA 01/2022
1	Protein Subunit VaccinesIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Adenine FDA LinkGeneric 01/2022
1	purineIBA 01/2022
1	Interferon Type IIBA 01/2022
1	Folic Acid AntagonistsIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	InterleukinsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Adenosine (Adenocard)FDA LinkGeneric 07/2021
1	Lipase (Acid Lipase)FDA Link 11/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2020
1	Carboplatin (JM8)FDA LinkGeneric 11/2020
1	pembrolizumabIBA 01/2020
1	Enhancer of Zeste Homolog 2 ProteinIBA 10/2019
1	VaccinesIBA 01/2019
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2019

Therapy/Procedure

20	Therapeutics 01/2023 - 04/2009
5	Neoadjuvant Therapy 02/2024 - 01/2020
5	Immunotherapy 12/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
2	Aftercare (After-Treatment) 11/2022 - 10/2018
2	Adjuvant Chemotherapy 01/2015 - 08/2004
1	Radiotherapy 02/2024
1	Precision Medicine 10/2021